Jane Street Group, LLC Ascendis Pharma A/S Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Jane Street Group, LLC holds 35,454 shares of ASND stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,454

Previous 16,261 118.03%

Holding current value

$4.6 Million

Previous $2.22 Million 138.79%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $2.17 Million - $2.94 Million	19,193 Added 118.03%	35,454 $5.29 Million
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $500,382 - $635,118	-4,133 Reduced 20.27%	16,261 $2.22 Million
Q1 2024 May 15, 2024	SELL	$123.45 - $159.4 $1.37 Million - $1.77 Million	-11,074 Reduced 35.19%	20,394 $3.08 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $581,261 - $859,807	6,751 Added 27.31%	31,468 $3.96 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $4.3 Million - $5.17 Million	-49,698 Reduced 66.78%	24,717 $2.31 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $4.2 Million - $5.88 Million	60,082 Added 419.19%	74,415 $6.64 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $4.04 Million - $4.89 Million	-38,560 Reduced 72.9%	14,333 $1.54 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $1.83 Million - $2.43 Million	-18,392 Reduced 25.8%	52,893 $6.46 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $2.58 Million - $3.39 Million	30,731 Added 75.78%	71,285 $7.36 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $2.58 Million - $3.39 Million	30,731 Added 75.78%	71,285 $7.36 Million
Q2 2022 Aug 16, 2022	BUY	$78.08 - $117.61 $942,581 - $1.42 Million	12,072 Added 42.38%	40,554 $3.77 Million
Q1 2022 May 17, 2022	BUY	$102.18 - $135.75 $1.42 Million - $1.88 Million	13,861 Added 94.8%	28,482 $3.34 Million
Q4 2021 Feb 15, 2022	BUY	$127.1 - $169.66 $1.01 Million - $1.35 Million	7,936 Added 118.71%	14,621 $1.97 Million
Q3 2021 Nov 16, 2021	BUY	$112.67 - $176.92 $277,618 - $435,930	2,464 Added 58.37%	6,685 $1.07 Million
Q1 2021 May 18, 2021	BUY	$124.92 - $173.33 $33,353 - $46,279	267 Added 6.75%	4,221 $544,000
Q4 2020 Feb 17, 2021	SELL	$151.2 - $182.76 $5.11 Million - $6.17 Million	-33,769 Reduced 89.52%	3,954 $659,000
Q3 2020 Nov 17, 2020	SELL	$134.29 - $154.32 $385,412 - $442,898	-2,870 Reduced 7.07%	37,723 $5.82 Million
Q2 2020 Aug 17, 2020	BUY	$110.87 - $156.01 $4.5 Million - $6.33 Million	40,593 New	40,593 $6 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $519,236 - $644,438	-5,420 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$107.11 - $132.09 $580,536 - $715,927	5,420 New	5,420 $624,000
Q2 2018 Aug 15, 2018	SELL	$58.55 - $73.92 $223,485 - $282,152	-3,817 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$38.98 - $68.04 $148,786 - $259,708	3,817 New	3,817 $250,000
Q4 2017 Feb 15, 2018	SELL	$31.98 - $40.38 $310,333 - $391,847	-9,704 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$26.89 - $37.1 $260,940 - $360,018	9,704	9,704 $352,000

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Ascendis Pharma A/S Transaction History